Lack of correlation between expression of retinoic acid receptor-beta and loss of heterozygosity on chromosome band 3p24 in esophageal cancer
- 22 May 2000
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 28 (2), 196-202
- https://doi.org/10.1002/(sici)1098-2264(200006)28:2<196::aid-gcc8>3.0.co;2-l
Abstract
Loss of heterozygosity (LOH) on chromosome arm 3p occurs frequently in human cancers, including esophageal cancer, suggesting that tumor suppressor genes may be located on this chromosome arm. The retinoic acid receptor‐beta (RARB) gene is localized on chromosome band 3p24, and its expression is progressively lost during esophageal carcinogenesis. Furthermore, growth inhibition of esophageal cancer cell lines by all‐trans retinoic acid has been associated with the constitutive and induced expression of RARB. We therefore assessed LOH on chromosome arm 3p and RARB expression in esophageal cancer to investigate the mechanism of altered RARB expression during carcinogenesis. We first analyzed LOH in 65 paired surgical specimens of normal mucosa and esophageal cancer by using 10 microsatellite markers, which resulted in 44 informative cases for subsequent study. LOH on chromosome band 3p24 was found to occur at an overall rate of 36.4% (16/44) by three markers (D3S1293, THRB, and D3S1283). LOH for these three individual markers was 14.0%, 47.4%, and 20.9%, respectively. Meanwhile, RARB expression was lost in 43.2% (19/44) of these 44 samples. The loss of RARB expression was not correlated with LOH on chromosome band 3p24 (γ = ‐0.22, ‐0.069, and ‐0.02, P = 0.15, 0.78, and 0.9 for D3S1293, THRB, and D3S1283, respectively), although both altered RARB expression and LOH in esophageal cancer were statistically significant (P = 0.001 and 0.0001, respectively), indicating that the loss of RARB expression cannot be explained by LOH on 3p24. Genes Chromosomes Cancer 28:196–202, 2000.Keywords
This publication has 31 references indexed in Scilit:
- Demethylation by 5-aza-2??-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor ?? gene in human colon carcinoma cellsAnti-Cancer Drugs, 1998
- Independent and Epigenetic Regulation of the Interleukin-4 Alleles in CD4 + T CellsScience, 1998
- Activation of the retinoic acid receptor ?? gene by 5-aza-2???-deoxycytidine in human DLD-1 colon carcinoma cellsAnti-Cancer Drugs, 1997
- Retinoic Acid Receptor β Mediates the Growth-Inhibitory Effect of Retinoic Acid by Promoting Apoptosis in Human Breast Cancer CellsMolecular and Cellular Biology, 1996
- Evidence for Impaired Retinoic Acid Receptor-Thyroid Hormone Receptor AF-2 Cofactor Activity in Human Lung CancerMolecular and Cellular Biology, 1995
- Nutrition Intervention Trials in Linxian, China: Supplementation With Specific Vitamin/Mineral Combinations, Cancer Incidence, and Disease-Specific Mortality in the General PopulationJNCI Journal of the National Cancer Institute, 1993
- Highlights of the Cancer Chemoprevention Studies in ChinaPreventive Medicine, 1993
- Chemoprevention of Skin Cancer in Xeroderma PigmentosumThe Journal of Dermatology, 1992
- Effect of retinoid status on α, β and γ retinoic acid receptor mRNA levels in various rat tissuesBiochemical Journal, 1992
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990